Tevogen Bio Insider Gifts 460k Shares, Retains Massive 62% Stake
Tevogen Bio Holdings Inc.
Subscribe to track TVGN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Tevogen Bio Insider Gifts 460k Shares, Retains Massive 62% Stake
Company: Tevogen Bio Holdings Inc. (N/A) Form: SCHEDULE 13D/A | Filed: 2025-12-16 Significance: Medium
Insider: Ryan H. Saadi Title: N/A | Relationship: 10% Owner
Transaction: • Type: Gift • Shares: 460,000 • Price: $0.00 • Value: $0 • Owned After: 124,528,376
Key Insight: A majority owner made a charitable gift representing ~0.23% of shares outstanding. While not a market sale, it's a notable disposition for a micro-cap company. The insider's control remains unchanged at ~62%.
Market Context: The gifted shares are valued at approximately $183,000 based on the company's $80M market cap. The insider's remaining stake is valued at ~$49.6M.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Tevogen Bio Holdings Inc. (N/A)
Executive Summary
- Trading Significance: Medium
- Key Takeaway: A majority owner, Ryan H. Saadi, gifted 460,000 shares to charity but maintains his controlling ~62% stake in the company.
- Market Impact: The transaction is a non-market disposition (gift) and does not signal a change in insider sentiment or control, suggesting a neutral market impact.
Company Information
| Field | Value |
|---|---|
| Company | Tevogen Bio Holdings Inc. |
| Ticker Symbol | N/A |
| CIK | 0001860871 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Ryan H. Saadi |
| CIK | 0002011728 |
| Title/Position | Not specified |
| Relationship | 10% Owner |
Transaction Details
| Field | Value |
|---|---|
| Form Type | SCHEDULE 13D/A |
| Transaction Date | 2025-12-11 |
| Transaction Code | G (Gift) |
| Security Type | Common Stock, par value $0.0001 per share |
| Shares Involved | 460,000 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 124,528,376 |
| Ownership Type | Direct and Indirect |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Implied Transaction Value | ~$183,080 (at ~$0.398/share) |
| % of Market Cap | ~0.23% |
| Shares Transacted | 460,000 |
| % of Shares Outstanding | ~0.23% |
| Post-Transaction Ownership | 124,528,376 shares (~62.0% of outstanding) |
| Materiality Assessment | Moderate |
Impact Evaluation
- Market Cap Context: For Tevogen Bio, a micro-cap company with an $80 million market capitalization, a transaction with an implied value of ~$183,000 is moderately significant. The percentages of market cap and shares outstanding (both ~0.23%) place this in the moderate tier.
- Ownership Concentration: The key takeaway is the insider's continued overwhelming control. The gift represents a negligible portion of his total holdings (<0.4%). His post-transaction ownership of ~62% means he remains the controlling shareholder, and this transaction does not alter the company's ownership structure in any meaningful way.
- Dilution Impact: Not applicable as this was a disposition of existing shares, not an issuance of new equity.
- Transaction Significance: The significance is rated Medium not because of the gift's market signal (which is neutral), but because any change in holdings by a 62% owner of a micro-cap company warrants attention. The transaction itself is a routine charitable donation.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-market gift to charity, not an open-market sale reflecting a change in the insider's investment thesis. The insider's controlling stake is unchanged, providing no new information to alter market perception.
Volume & Sentiment
- Expected Volume Impact: Low. As a non-market transaction, it will not directly impact trading volume. It is unlikely to spur significant secondary trading activity.
- Sentiment Indicator: Neutral. The filing confirms the majority owner's massive stake while noting a minor, philanthropic disposition.
Investment Insights
Positive Market Indicators
- The insider maintains a very large controlling interest of ~62%, indicating continued long-term alignment with the company's success.
Risk Factors
- High ownership concentration in a single individual can pose corporate governance risks.
Key Takeaways
- No Change in Control: The primary insider, Ryan H. Saadi, remains firmly in control with a ~62% stake after the gift.
- Non-Market Transaction: The gift to charity is not an indicator of negative sentiment, unlike a large open-market sale.
- Moderate Materiality: The size of the gift is notable relative to the company's small market cap but is insignificant compared to the insider's total holdings.
Additional Context
Transaction Notes
- The filing is an amendment to a Schedule 13D, required for beneficial owners of more than 5% of a company's stock, to report a material change in their holdings.
- The shares were gifted to unspecified charitable entities.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
